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Abstract 
 
Enteric fever, caused by infection with Salmonella Typhi or Paratyphi A, B, or C (typhoidal Salmonella) and 
melioidosis are among the most common bacterial causes of acute febrile illness in tropical and subtropical 
countries. The diseases are widely spread even in developed countries mainly affecting travellers returning from 
endemic areas. Melioidosis is an increasingly recognized fatal septicemic infection also mimicking tuberculosis. 
These pathogens are largely underreported due to lack of sensitive and specific diagnostic tools. In this study, an 
inhouse multiplex real-time PCR assay was developed for the simultaneous detection of Salmonella Typhi, S. 
Paratyphi A and B. pseudomallei using specific primers. The inhouse developed assay was evaluated on buffy coat 
and serum samples collected from patients with acute febrile illness at four different centres. The assay had a 
detection limit of less than 1 genome copy for S. Typhi and S. Paratyphi A and 18 genome copies per 10 µl of PCR 
input for B. pseudomallei. Among the 1101 samples tested by multiplex real-time PCR, one (0.09%) sample was 
positive for S. Typhi. One sample was positive for blood culture identified as S. Typhi but negative by real-time 
PCR. The samples were negative for S. Paratyphi A and B. pseudomallei. The multiplex real-time assay would be 
highly useful as a diagnostic aid for the syndromic approach and comprehensive diagnosis of enteric fever and 
melioidosis. The assay could improve the overall diagnostic capability and be a useful tool during outbreak 
investigations. 
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Introduction 
 
Acute febrile illness is a common presentation in 
many healthcare setting and the etiological agents are 
very diverse.  
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Early and reliable detection is an essential step in the 
management of infectious diseases. The timely 
diagnosis and treatment are trivial due to lack of 
rapid, sensitive and specific diagnostic tools resulting 
in presumptive diagnosis and empirical treatment 
with antimicrobials. Early detection would help 
provide appropriate patient care, prevent outbreaks, 
and determine treatment outcome [1]. In syndromic 
diagnosis, where different pathogens present with 
similar symptoms, the use of highly sensitive and 
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specific diagnostic methods would help in 
understanding the real spectrum of a particular 
disease in the specific geographic population [2]. 
Pathogens such as Salmonella Typhi, Salmonella 
Paratyphi A and Burkholderia pseudomallei are the 
important causes of acute febrile illness especially in 
tropical and subtropical countries [3,4]. These 
pathogens contribute to the global burden with a high 
incidence rate in South Asia, sub-Saharan Africa, 
East Asia and Pacific. High rates of newly diagnosed 
cases are reported in Regions such as North America 
and Europe and Central Asia through travel from 
endemic areas [5]. This indicates the importance of 
early detection and prompt treatment. Multiplex 
assays are now considered an appropriate clinical 
diagnostic application especially when the 
identification of etiological agent is challenging [6]. 
The study was aimed to develop an inhouse multiplex 
real-time PCR for the detection of the three important 
pathogens and to look at the frequency of these 
pathogens in patients presenting with acute febrile 
illness.  
 
Materials and Methods 
In this study, a multiplex real-time PCR assay was 
developed and evaluated on clinical samples 
collected from patients with acute febrile illness.  
Inhouse multiplex real-time PCR 
The multiplex real-time PCR cocktail contained 
primers and probes specific for S. Typhi, S. Paratyphi 
A and B. pseudomallei (Table 1). Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), a housekeeping 
gene, was used as internal amplification control. The 
target genes for PCR amplification were selected 
based on previous literature that has demonstrated 
high sensitivity and specificity in clinical samples. 
Species-specific primers and probes were designed 
by using IDT oligo design software. The identified 
primer and probe sequences were cross-checked for 
specificity by BLAST analysis. Primers and probes 
were obtained from commercial sources (Eurofins, 
India). Upon receipt, the lyophilized primers and 
probes were resuspended in TE buffer (10 mM 
Tris•Cl, 1 mM EDTA, pH 8.0) to provide a stock 
solution of 100 μM, and divided into small aliquots to 
avoid repeated freeze-thaw. 
 
                                                        Table 1: List of primers and probes used in the study 
Pathogens Forward primer^ Reverse Primer^ Probe^ 
Salmonella 
Typhi 
GCTCTAAAACACTGGGACTTG TCTGGGCTGTAATAGGATCTG 6-FAM - 
TGTAGGCATCTTGGA
CATTAAGC - BHQ1 
Salmonella 
Paratyphi A 
GTCAGGATCAGTAAGCATGTG TCCTTGCCGTATTTTCTATGC HEX - 
AGTCATTTTCCGTAT
AAACTCCACC - 
BHQ1 
Burkholderia 
pseudomallei 
TCAACCCCATGAGATCGAG 
 
GCAAATGGTCACGAAGCTC 
 
CY5 - 
ATTTCGCCTTCGGAT
TCGC - BHQ2 
GAPDH# GGAAACTGTGGCGTGATG CGTTCAGCTCAGGGATG TexasRed - 
AGTAGAGGCAGGGA
TGATGTT -  BHQ2 
     #Internal amplification control^The oligonucleotide sequences are given as 5' to 3' position. FAM, HEX, Cy5 & 
texas red are the fluorescent dyes; BHQ1 & 2 are quencher dyes 
   S. Typhi: Salmonella enterica subsp. enterica serovar Typhi strain encoding FliC region; NCBI accession No. 
CP029646; nucleotide position: 1965599    to 1965718. 
S. Paratyphi: Salmonella enterica subsp. enterica serovar Paratyphi A strain encoding a hypothetical protein; 
NCBI accession No. FM200053; nucleotide position: 2572476 to 2572583 
B. pseudomallei: Burkholderia pseudomallei MSHR305 chromosome 2 encoding epaR gene, a type III secretion 
apparatus protein; NCBI accession No. CP006469; nucleotide position: 1520940 to 1521049 
GAPDH: Homo sapiens glyceraldehyde-3-phosphate dehydrogenase (GAPDH), transcript variant 1, mRNA; 
NCBI accession No. NM_001289745.2; nucleotide position: 746 to 844. 
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Synthetic DNA constructs of 250 basepairs 
harbouring the PCR amplification region cloned in a 
suitable plasmid vector were commercially 
synthesized and obtained (Eurofins, India). The DNA 
constructs for all the three pathogens and the 
housekeeping gene were used to ascertain the lower 
limit of detection (assay sensitivity). The synthetic 
DNA templates were also used as a positive control 
in all the real-time PCR assays. In the real-time PCR 
setup for patient sample testing, a negative control 
was included as every third sample by replacing 
DNA template with nuclease-free water. The 
functionality of each set of primers and probe were 
checked in uniplex PCR assays against cloned gene 
constructs before combining the different sets in a 
multiplex PCR assay and the same were optimized 
for high specificity and sensitivity of detection. The 
real-time multiplex PCR amplification was 
performed as 25μl reactions using by QuantiTect 
Multiplex PCR NoROX master mix (Qiagen, 
Hamburg, Germany) in Rotor-Gene Q 5-plex System 
(Qiagen, GmbH, Germany). DNA extract (10μl), 
forward and reverse primer at a final concentration of 
1.5 picomoles each and probe at a final concentration 
of 0.5 picomoles. The thermal profile includes initial 
activation at 95°C for 15 min followed by 45 cycles 
of Denaturation at 94°C for 60 sec and 
annealing/extension at 60°C for 60 sec. Amplification 
in a typical sigmoid curve within the 40th cycle with a 
minimum of 0.05 fluorescence intensity was 
considered as the cut-off for real-time PCR as 
previously described (Herthnek and Bölske, 2006). 
The samples that showed amplification after the 35th 
cycle were retested in uniplex format. Those samples 
that were positive on retesting alone were considered 
as true positives. 
Establishment of the lower limit of detection  
The cloned plasmids were serially diluted down 10-
fold in TE buffer (pH 8.0) (Invitrogen, Thermo 
Fisher Scientific, Vilnius, Lithuania) within the 
concentration range of 10-1 to 10-12. Each dilution was 
tested in triplicates by the inhouse real-time PCR in 
uniplex format individually for each target gene. 
Appropriate negative controls were included. 
Amplification shown in the highest dilution (least 
concentration) in at least two of the triplicates tested 
on each dilution was taken as the lower limit of 
detection and expressed as plasmid copies per 
microliter.  
Subject recruitment and sample collection 
Patients presenting with acute febrile illness were 
recruited from Sri Narayani Hospital and Research 
Centre (SNHRC), a 300-bed multispecialty hospital 
serving in the rural area of Vellore district, South 
India. Blood samples were collected from patients 
after obtaining informed consent/assent in English or 
vernacular language. A detailed clinical proforma 
was obtained from each patient during the sample 
collection. Ethical approval from the Institutional 
Review Board has been obtained for the study 
(IEC/IRB No: 27/16/09/13). Samples from a total of 
536 patients were collected and separated into two 
parts. One part was used for blood culture in 
BacTAlert system and the other was collected in a 
vacutainer containing EDTA. Blood culture bottles 
flagging positive signals were processed for bacterial 
identification and antimicrobial susceptibility testing 
using standard methods [7]. The blood culture 
remained as the gold standard for the three pathogens 
tested. Buffy coat was separated from the EDTA 
blood as described previously (Nandagopal et al. 
2010). Buffy coat was suspended in phosphate buffer 
saline (pH 7.3) and plasma samples were stored at -
20°C until use. Blood or serum samples collected 
from patients with acute febrile illness collected from 
three other collaborating institutions were also tested. 
The three centres include (1) an upgraded primary 
health centre (PHC), Ussoor, Vellore, (2) a medical 
research institute and reference centre called King 
Institute of Preventive Medicine (KIPM), Chennai, 
Tamil Nadu and (3) a tertiary care medical college, 
Pushpagiri Institute of Medical Sciences (PIMS), 
Thiruvalla, Kerala. Blood culture was carried out for 
all the samples obtained from the parent study centre 
(SNHRC). The blood samples obtained from PHC 
was available only for buffy coat preparation and the 
other two collaborating institutions shared only 
serum samples. The inhouse multiplex real-time PCR 
testing was carried out on all samples (n=1101) and 
rapid card IgG/IgM anti-S. Typhi and anti-S. 
Paratyphi testing was done on random samples 
(n=178) (Table 2). 
 
 
Asian Pac. J. Health Sci., 2019; 6(2):88-95                                              e-ISSN: 2349-0659, p-ISSN: 2350-0964 
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Saravanan et al                                    ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2019;6(2):88-95                                  91 
www.apjhs.com       
 
Table 2: Samples tested from four different study centres 
Study centres Samples 
collected (n) 
Nature of 
sample 
Blood 
culture 
Real-time 
PCR 
TyphiDot on random 
samples (n=178) 
Sri Narayani Hospital and Research 
Centre 
536 Whole blood* 1 - 10/143 IgG and IgM 
1/143 IgM 
Upgraded PHC, Ussoor 184 Whole blood* - - ND 
King Institute of Preventive Medicine 
and Research 
120 Serum - 1 0/27 
Pushpagiri Institute of Medical Sciences 261 Serum - - 0/8 
*Buffy coat was separated from the whole blood and used for PCR; ND - not done. 
Real-time PCR testing on clinical samples 
DNA was extracted from buffy coat/serum using 
QiaAmp DNA mini kit (Qiagen, Hilden, Germany) 
according to the manufacturer's instructions. During the 
DNA extraction setup, every fifth sample acted as an 
extraction control replacing the clinical sample with 
PCR-grade nuclease-free water. This was carried out to 
ensure the absence of inhibitory substances on 
extraction. A total of 1101 samples were collected from 
all the four centres as either whole blood or serum. The 
samples were tested for the three pathogens by the 
inhouse developed multiplex real-time PCR. The 
housekeeping gene, GAPDH was included in the 
cocktail and acted as internal amplification control. 
DNA samples extracted from standard strains (S. Typhi, 
S. Paratyphi A, Burkholderia cepacia) and an inhouse B. 
pseudomallei strain were tested for proficiency testing. 
For heterologous testing, DNA extracted from bacterial 
cultures including, Escherichia coli, Pseudomonas 
species, Klebsiella species were prepared and tested by 
the multiplex real-time PCR assay. 
Test for IgG / IgM typhoid fever: From the overall 
samples (n=1101), a set of random samples (n=178) 
were generated. These samples along with two samples 
positive for Salmonella by blood culture were tested for 
IgM and IgG anti - S. Typhi and S. Paratyphi using 
OnSite Typhoid IgG/IgM rapid lateral flow 
immunoassay test kits (CTK Biotech Inc, California, 
USA) according to manufacturer's instructions.  
 
Results 
An inhouse multiplex real-time PCR for the 
simultaneous detection of S. Typhi, S. Paratyphi A and 
B. psedomallei was developed. The primers and probes 
were found to be highly (100%) homologous and 
specific to each target pathogen as identified by BLAST 
analysis. The inhouse multiplex real-time PCR testing 
was carried out on all samples (n=1101) and rapid card 
IgG/IgM anti-S. Typhi and anti-S. Paratyphi testing was 
done on random samples (n=178).The samples from 
different areas were recruited to look at the frequency of 
enteric fever and melioidosis in patients presenting with 
acute febrile illness. This is a prospective study and 
cross-sectional in nature. The parent study centre, 
SNHRC mainly serves rural and peri-urban areas of 
Vellore district, India and the PHC serves rural and 
tribal areas of Vellore district. The KIPM centre is a 
regional node and a state reference laboratory in 
Chennai, India. Serum samples received from patients 
with acute febrile illness for routine serological 
diagnostics were randomly picked and shared for this 
study. At PIMS, samples were collected from patients 
during the monsoon and post monsoon floods of August 
2018 in Kerala.The inhouse developed multiplex real-
time PCR assay showed specific amplification for the 
three pathogens in the respective channels. Standard 
strains and inhouse strains also tested positive for the 
respective pathogens in the appropriate channels. The 
detection limit for each target pathogen in the real-time 
PCR assay was determined. The in-house real-time PCR 
assay had a detection limit of less than 1 genome copy 
per 10 µl of PCR input for S. Typhi and S. Paratyphi A, 
and 18 genome copies per 10 µl of PCR input for B. 
pseudomallei, indicating a high assay sensitivity. The 
detection limit for GAPDH was 43 genome copies per 
10 µl of PCR input. In the heterologous testing, the 
multiplex real-time PCR did not amplify other 
pathogens indicating high specificity.A total of 1101 
samples as blood or serum were collected from patients 
presenting with acute febrile illness from different 
centres. Of these, males were 645 and females were 436 
(details of 20 patients were not available) and age 
ranged from 12 days to 92 years (median, 44). Of 536 
samples collected from SNHRC for which blood culture 
data was available, 106 samples flagged positive and upon 
further testing, coagulase-negative Staphylococcus (n=55) 
was predominant followed by Escherichia coli (n=16) and 
Klebsiella species (n=6). Blood culture was negative for S. 
Paratyphi A and B. pseudomallei. Among the 1101 samples 
tested by multiplex real-time PCR, one (0.09%) sample was 
positive for S. Typhi (Fig. 1). This sample from KIPM was 
obtained as a serum sample. Among 536 samples, for 
which blood culture data was available, one sample 
positive in blood culture was identified as S. Typhi based 
on culture and sero-agglutination and one other blood 
culture positive sample was identified as non-typhoidal 
salmonella. Both the samples were negative by real-time 
PCR. The samples were negative in blood culture for S. 
Paratyphi A and B. pseudomallei. 
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Fig 1:The real-time PCR amplification curve for a sample positive for S. Typhi 
 
The major clinical presentation among the patients 
were gastrointestinal symptoms (40%) including 
diarrhea, nausea, vomiting, abdominal pain, abdominal 
tenderness, hepatomegaly and hepatosplenomegaly. 
Mild fever (< 100°F) was recorded in 220 (41%) 
patients, moderate fever (100 - 102°F) was recorded in 
273 (51%) patients and high-grade fever (>102°F) was 
recorded in 33 (6.2%) patients. Majority of them had 
an undulating fever (88.5%) and a few had prolonged 
fever (8.5%). About 3% of the patients reported with 
rashes 
(erythematous/macular/maculopapular/purpuric). Other 
important clinical features such as myalgia, cough, 
hematuria, loss of weight, co-morbidities such as 
diabetes, hypertension and renal disease were also 
recorded. 
Samples (n=46) among 536 samples collected at 
SNHRC, were tested for Widal as part of routine 
investigations. Of these, 33 samples were positive. 
Fourteen patients had 1:80 titre for both STO and STH 
and five patients had 1:160 titre for both STO and 
STH. Eleven patients had a titre of 1:160 for STO and 
1:80 for STH; and three patients had 1:80 for STO 
only. The sample positive for culture had 1: 160 titre 
for STO and STH.Among the 180 random samples 
tested for IgG/IgM-anti-S. Typhi and S. Paratyphi A, 
10 samples were positive for both IgG and IgM and 
one sample was positive for only IgM. Among the 
samples tested, an additional 12 samples including the 
sample that was S. Typhi positive by blood culture, 
produced a faint band for IgG and IgM and one 
additional sample produced a faint band for IgM and 
these 13 were not considered as confirmed positive. 
The other sample that was identified as non-typhoidal 
salmonella was negative by TyphiDot. 
 
Discussion 
An inhouse multiplex real-time PCR was developed for 
the detection of three pathogens, S. Typhi, S. Paratyphi 
A and B. pseudomallei and evaluated in patients with 
acute febrile illness. Typhoid and paratyphoid fever 
commonly called as enteric fever, is caused by 
Salmonella enterica serovar Typhi (S. Typhi) and 
Salmonella enterica serovar Paratyphi (S. Paratyphi). 
A systematic analysis for the global burden of diseases 
in the year 2017 reported 14.3 million cases of typhoid 
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and paratyphoid fevers with a case fatality of 0·95% 
[8]. The rates are estimated to be higher in children and 
among the elderly population. Typhoid fever is an 
acute and life-threatening systemic infection with 
significant morbidity and mortality especially in 
developing countries where there is limited access to 
safe drinking water, good sanitation and hygienic 
practices [9]. The infection mostly present with protean 
manifestations but commonly with high-grade fever, 
headache, malaise and gastrointestinal symptoms 
(abdominal pain, vomiting, diarrhea), hepatomegaly 
and splenomegaly [10]. Culture from the body fluids 
remains the gold standard for the diagnosis, of which 
bone marrow culture is considered superior. Due to the 
unpleasant invasive procedure of collecting bone 
marrow, blood culture is preferred. For the definite 
diagnosis of typhoid fever, the sensitivity of the blood 
culture compared to bone marrow culture was found to 
be 66% and hence estimation of disease burden based 
on blood culture will be an underestimate [11]. Apart 
from the sample volume, several factors such as 
patients' duration of fever, prior antimicrobial use and 
laboratory conditions are known to highly influence the 
sensitivity of the blood culture [12]. These factors 
along with low bacterial counts in the blood and 
nonspecific clinical features complicate the clinical 
diagnosis. Widal test based on serology is used 
commonly in spite of its limitations in sensitivity 
because of ease in use and cost-effectiveness. There are 
both technical and clinical drawbacks in testing both 
acute and convalescent-phase serum samples collected 
one week apart and looking for an increase in antibody 
titre for the appropriate interpretation. In a meta-
analysis on the diagnostic accuracy of different 
commercially available rapid diagnostic tests such as 
TyphiDot, an average sensitivity of 78% and 
specificity of 87% were observed with no difference in 
false positive rates [13]. In our study, of the 178 
random samples tested for rapid card IgG/IgM-anti-S. 
Typhi and S. Paratyphi A, 10 samples were positive for 
both IgG and IgM and one sample was positive for 
only IgM. Additional 12 samples produced a faint band 
for IgG and IgM were not considered as true positives. 
The sample that was identified as S. Typhi from blood 
culture gave faint bands for both IgM and IgG and the 
sample that was identified as non-typhoidal Salmonella 
was negative for both IgM and IgG. In serological 
diagnosis, IgM is expected in the acute phase of illness 
and IgG in past infection. The rapid card devices have 
low sensitivity and specificity albeit it is easy to use. It 
is important for the clinicians to be cautious and not 
have too much of dependence on these devices for 
diagnosis of enteric fever which could lead to 
erroneous diagnosis and use of unnecessary antibiotics. 
B. pseudomallei causes melioidosis and is endemic in 
most parts of southeast Asia with a fatality rate of up to 
30% [14]. It generally presents with fever, abscess, 
acute pneumonia and septicemia and is called a great 
imitator of tuberculosis [15]. Rapid detection of B. 
pseudomallei would help initiate early antimicrobial 
therapy that could significantly improve patient 
outcome. While blood culture is the standard approach, 
the low detectable limit of the pathogen in the blood 
(~1 CFU/mL) hampers the timely diagnosis and 
treatment [16]. The isolation rate of enteric fever and 
melioidosis is generally low and therefore in our study, 
samples from multiple sampling sites were chosen and 
tested. Acute febrile illness is caused by a wide range 
of pathogens and is common in tropical and subtropical 
countries. The traditional diagnostic approach of blood 
culture is time-consuming and the reliance on IgM/IgG 
testing poses a risk of false positives. The automated 
identification system is still beyond reach. In a recent 
multisite surveillance study, a total of 267536 blood 
cultures were retrospectively analyzed and 0.53% of 
which was positive for S. Typhi and S. Paratyphi 
indicating a relatively low isolation rate of S. Typhi in 
India [17]. In our study, among blood culture positives 
in 536 samples, we found two cultures each identified 
as S. Typhi and non-typhoidal Salmonella. In real-time 
PCR, one sample was identified from a serum sample.  
Molecular detection by PCR is generally considered a 
rapid and highly sensitive and specific approach for the 
detection of pathogens especially the uncultivable or 
undetectable etiological agents. S. Typhi, S. Paratyphi 
A and B. pseudomallei being potential agents of acute 
febrile illness and not detectable in conventional 
culture techniques due to various reasons, we 
developed a multiplex real-time PCR for the detection 
of these pathogens and evaluated in patients with acute 
febrile illness. A multiplex PCR for the simultaneous 
detection of Burkholderia species have been reported 
previously [18–20] but was not evaluated in clinical 
samples. Other studies have reported multiplex PCR 
for the detection of B. pseudomallei along with 
Brucella species, Bacillus anthracis and Yersinia pestis 
[21] but the assay was not evaluated in clinical 
samples. We previously showed the usefulness of 
multiplex PCR for the detection of B. pseudomallei 
along with S. Typhi and Mycobacterium tuberculosis in 
the buffy coat samples compared to blood culture [22]. 
The routine blood culture was able to identify one extra 
typhoid case compared with real-time PCR. While both 
whole blood and buffy coat are proved to be a useful 
clinical specimen for the detection of S. Typhi, the 
recovery rate from these samples might differ due to a 
number of reasons. It has been shown that the varied S. 
Typhi count in the whole blood of patients could be 
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attributed to the disease severity, duration of illness and 
patient's age. The viable pathogens, expressed as CFU, 
were found to be spread more in the buffy coat layer 
(62.5%) compared to erythrocyte and plasma layers 
(37.5%). The S. Typhi count in the whole blood was 
found to be three times higher in children less than 15 
years of age compared to adults [23].  
PCR negativity in the one culture-positive for S. 
Typhi  may be attributed to following  reasons. Widal 
at 1:160 titre (for STO and STH) and TyphiDot 
positivity suggested an active infection. Though PCR 
detection limit was less than one genome copy, the 
determination was not performed in spiked clinical 
sample but in titrated plasmid dilutions. PCR inhibitors 
are a possible cause [24]. But the possibility of PCR 
inhibitors were ruled out because the amplification of 
internal amplification control (GAPDH) was 
satisfactory. Blood culture is generally incubated for up 
to seven days. The blood culture in this case was 
positive after 36 hours of incubation. This would have 
enhanced the bacterial growth from the sample with 
possibly a very low bacterial load. While in PCR, the 
input could be low since buffy coat was extracted on 
day-one without enrichment of bacterial cells. The 
other possibility is "poor yield of buffy coat and 
thereby insufficient DNA quantity" from the patient's 
blood sample. The blood sample was drawn for both 
blood culture and buffy coat separation at the same 
time, so blood volume for buffy coat preparation might 
have been compromised. From our previous 
experience, buffy coat separated from 5mL of blood 
was sufficient for all PCR assays [22,25,26].Our 
inhouse multiplex real-time PCR assay was able to 
identify the inhouse standard strains, S. Typhi, S. 
Paratyphi A and B. pseudomallei efficiently and did 
not amplify other pathogens during heterologous 
pathogens testing. This indicates its high assay 
specificity. The lower limit of detection experiment 
indicated that the multiplex real-time PCR assay has 
high sensitivity. It is imperative that the real-time PCR 
assay along with blood culture provides the benefits of 
increased diagnostic yield. The assay could thus help 
improve laboratory diagnosis in high-incidence settings 
especially when enteric fever and melioidosis is 
suspected. The one real-time PCR positive was from 
serum sample and blood culture data was not available. 
The number of blood cultures positive were low and 
therefore diagnostic accuracy indices were not 
calculated. Despite these limitations, we recommend 
the real-time PCR assay for its multiplexing capability, 
lower detection limit and short turnaround time.In the 
present study, the multiplex real-time PCR was 
developed targeting specific genes that are suitable for 
the multiplex format. The inhouse assay was highly 
sensitive in terms of lower detection limit down to less 
than 1 genome copy for S. Typhi and S. Paratyphi A 
and 1.8 genome copies for B. pseudomallei per 
microlitre of PCR input. The assay also showed 
specific amplification with inhouse standard strains 
with no cross-reactivity with other related pathogens 
indicating a high specificity. The assay thus could be 
highly useful as a diagnostic aid for the syndromic 
approach and comprehensive diagnosis of enteric fever 
and melioidosis. Such PCR assays could help rapidly 
diagnose during an outbreak situation and initiate 
appropriate patient management. The assay could 
improve the overall diagnostic capability and disease 
surveillance. 
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